Theratechnologies Inc (THERF) 1.4340

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Theratechnologies Inc (THERF) 1.4340 $THERF

Theratechnologies to Announce Financial Results for the Second Quarter of 2015
Marketwired - Fri Jun 26, 11:18AM CDT
Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the second quarter ended May 31, 2015, on Tuesday, July 14, 2015, before markets open.
TH.TO: 1.84 (+0.15)

Lipodystrophy Therapeutics Pipeline Review, H1 2015 - 6 Companies & 6 Drug Profiles
M2 - Tue Jun 09, 6:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hd9j66/lipodystrophy) has announced the addition of the "Lipodystrophy - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Lipodystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Lipodystrophy and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Aileron Therapeutics, Inc. - Ambrx, Inc. - AstraZeneca PLC - Bolder Biotechnology, Inc. - Theratechnologies Inc. - Zydus Cadila Healthcare Limited Drug Profiles - ALRN-5281 - ARX-328 - BBT-031 - metreleptin - saroglitazar - tesamorelin acetate For more information visit http://www.researchandmarkets.com/research/hd...odystrophy
AMBX: (), AZN: 66.45 (+1.90)

Announcements in Conjunction With Theratechnologies Annual Meeting
Marketwired - Wed May 20, 10:43AM CDT
Theratechnologies Inc. (TSX: TH) today held its annual meeting of shareholders, chaired by Dawn Svoronos, chair of the board of Theratechnologies.
TH.TO: 1.84 (+0.15)

Authorization to Discontinue Class Action Proceedings Against Theratechnologies Granted
Marketwired - Fri May 15, 10:00AM CDT
Theratechnologies Inc. (TSX: TH) today announced that the Superior Court of Quebec has authorized 121851 Canada Inc. to discontinue all class action proceedings filed pursuant to the Securities Act (Quebec) and the Civil Code of Quebec against the Company, a director and a former president and chief executive officer.
TH.TO: 1.84 (+0.15)

Cognitive Impairment - Pipeline Review, H1 2015
M2 - Thu May 14, 5:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z64d6n/cognitive) has announced the addition of the "Cognitive Impairment - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Cognitive Impairment, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cognitive Impairment and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - AbbVie Inc. - AstraZeneca PLC - Avineuro Pharmaceuticals, Inc. - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - Dart NeuroScience LLC - Eisai Co., Ltd. - Eli Lilly and Company - Evotec AG - F. Hoffmann-La Roche Ltd. - FORUM Pharmaceuticals Inc. - H. Lundbeck A/S - Iproteos S.L. - Merck & Co., Inc. - Mithridion, Inc. - Mnemosyne Pharmaceuticals, Inc. - Neuralstem, Inc. - Novartis AG - Panacea Pharmaceuticals, Inc. - Pfizer Inc. - Pherin Pharmaceuticals, Inc. - Sanofi - Shire Plc - Suven Life Sciences Ltd. - Takeda Pharmaceutical Company Limited - Teva Pharmaceutical Industries Limited - Theratechnologies Inc. - Upsher-Smith Laboratories, Inc. - Vicore Pharma AB - Virogenomics, Inc. For more information visit http://www.researchandmarkets.com/research/z64d6n/cognitive
PFE: 34.36 (+0.50), LLY: 88.29 (+0.81), BMY: 69.27 (+1.38), AZN: 66.45 (+1.90), MRK: 57.95 (+0.57), SHPG: 250.34 (+7.35), TEVA: 61.38 (-0.75), ABBV: 69.23 (+1.26), CUR: 1.69 (-0.01), NVS: 103.22 (+3.20)

Supreme Court of Canada Rules in Favour of Theratechnologies
Marketwired - Fri Apr 17, 9:09AM CDT
Theratechnologies Inc. (TSX: TH) announced today that the Supreme Court of Canada has granted its appeal and dismissed 121851 Canada Inc.'s motion for leave to commence an action based on the secondary market liability provisions of the Securities Act (Quebec) against Theratechnologies, one of its directors and a former president and chief executive officer.
TH.TO: 1.84 (+0.15)

Theratechnologies Announces Financial Results for First Quarter of 2015
Marketwired - Tue Apr 14, 6:01AM CDT
Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the first quarter ended February 28, 2015.
TH.TO: 1.84 (+0.15)

Theratechnologies to Announce Financial Results for the First Quarter of 2015
Marketwired - Tue Apr 07, 11:43AM CDT
Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the first quarter ended February 28, 2015, on Tuesday, April 14, 2015, before markets open.
TH.TO: 1.84 (+0.15)

IIROC Trade Resumption - Theratechnologies Inc.
Newsfile Corp - Tue Mar 31, 7:00AM CDT
Trading resumes in:

Health Canada Approves 1mg/vial Presentation of EGRIFTA(TM) (tesamorelin for injection)
Marketwired - Mon Mar 30, 3:28PM CDT
Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Health Canada has approved a Supplement to a New Drug Submission for the 1mg/vial presentation of EGRIFTA(TM) (tesamorelin for injection) (EGRIFTA(TM)).
TH.TO: 1.84 (+0.15)

IIROC Trade Halt - Theratechnologies Inc.
Newsfile Corp - Mon Mar 30, 2:59PM CDT
The following issues have been halted by IIROC:

Theratechnologies Announces Voluntary Filing of Form 15 to Suspend SEC Reporting Obligations
Marketwired - Tue Feb 03, 6:16AM CST
Theratechnologies Inc. (TSX: TH) today announced that it has filed a Form 15 with the Securities and Exchange Commission ("SEC" under the Securities Exchange Act of 1934, as amended, (the "Exchange Act" to suspend its reporting obligations under Section 15(d) of the Exchange Act.
TH.TO: 1.84 (+0.15)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 97

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 302

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 158

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 203

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 216

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 385

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Blend's AWS Financial Services Competency Enhances Innovations

Updated Category News Views 152

Blend Takes a Major Stride with AWS Financial Services Competency Exciting news emerges from Blend as the company secures a crucial recognition in the cloud technology arena. They've recently achieved the prestigious AWS Financial Services Competency badge, a testament to their outstanding expertise and remarkable track record in delivering innovative, secure, and...

Continue Reading
The Upcoming Surge of Last Mile Delivery Market Growth

Updated Category News Views 289

Overview of the Last Mile Delivery Market Growth The Last Mile Delivery market is poised for significant growth in the coming years, projected to rise by USD 51.1 billion from 2025 to 2029. This increase is primarily driven by the expanding global e-commerce sector and the integration of advanced technologies, including AI, which are transforming logistical operations....

Continue Reading
Tide Rock Expands Its Precision Machining Horizons Through Acquisitions

Updated Category News Views 326

Tide Rock Expands Its Precision Machining Horizons Tide Rock has taken a significant leap forward in the field of advanced precision machining through its recent acquisitions. By acquiring Precision Waterjet & Laser, now known as Precision Advanced Machining, located in Anaheim, California, and Made in America Manufacturing based in Buda, Texas, Tide Rock is enhancing its...

Continue Reading
Novavax Revises Projections, Anticipates Robust Nuvaxovid Demand

Updated Category News Views 149

Novavax Reports Strong Second Quarter Results Recently, Novavax Inc. reported impressive sales of $239.24 million for the second quarter of 2025, marking a significant shift from $415 million during the same period in the previous year. This figure exceeded the Wall Street consensus expectations, which estimated sales at $156.29 million. Such growth highlights Novavax's...

Continue Reading
Insights into Novartis' Cosentyx and GCAptAIN Study Findings

Updated Category News Views 219

Novartis' Groundbreaking Updates on Cosentyx in GCAptAIN Study Novartis has recently provided significant updates regarding the Phase III GCAptAIN study, focusing on the efficacy of Cosentyx (secukinumab) for patients suffering from giant cell arteritis (GCA). This condition, predominantly affecting older adults, poses a risk of severe complications if not managed...

Continue Reading